Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
News
Taxes
Watchlists
My Portfolio
My Screeners
Market Data
Industry News
Real Estate
Technology
Currency Converter
Canada markets closed
S&P/TSX
22,465.37
+165.54
(+0.74%)
S&P 500
5,303.27
+6.17
(+0.12%)
DOW
40,003.59
+134.21
(+0.34%)
CAD/USD
0.7348
+0.0002
(+0.03%)
CRUDE OIL
80.00
+0.77
(+0.97%)
Bitcoin CAD
91,118.89
+2,257.48
(+2.54%)
Oncolytics Biotech Inc. (ONYN.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.6100
0.0000
(0.00%)
At close: 09:08AM CEST
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
19,913
17,709
15,432
12,920
12,945
Selling General and Administrative
15,467
15,679
11,100
12,863
12,514
Total Operating Expenses
35,783
33,791
26,924
26,235
25,459
Operating Income or Loss
-35,783
-33,791
-26,924
-26,235
-25,459
Total Other Income/Expenses Net
6,164
4,810
1,645
-119
2,833
Income Before Tax
-28,112
-27,655
-24,751
-26,255
-22,505
Income Tax Expense
-
97
84
49
0
Income from Continuing Operations
-28,209
-27,752
-24,835
-26,304
-22,505
Net Income
-28,209
-27,752
-24,835
-26,304
-22,505
Net Income available to common shareholders
-28,209
-27,752
-24,835
-26,304
-22,505
Basic EPS
-
-
-
-
-0.56
Diluted EPS
-
-
-
-
-0.56
Basic Average Shares
-
-
-
-
40,339
Diluted Average Shares
-
-
-
-
40,339
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy Dashboard
About Our Ads
© 2024 Yahoo. All rights reserved.